To the best of our knowledge, this study is the first to conduct a comprehensive and systematic pan-cancer analysis of ABCA10 and ABCB5, exploring their correlations with immune cell infiltration and drug responses across multiple cancer types utilizing advanced multiomics tools. This evidence concerns the gene ABCA10 and cancer.